EP2904011
Samsetning á and-KIR mótefnum og and-PD-1 mótefnum til meðferðar á krabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.10.2013EP published:
23.8.2017EP application number:
13774596.4
EP translation filed:
10.10.2017Grant published:
15.11.2017EPO information:
European Patent Register
Max expiry date:
1.10.2033Expiry date:
1.10.2024
Title:
COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER
Timeline
Today
2.10.2013EP application
23.8.2017EP Publication
10.10.2017Translation submitted
15.11.2017Registration published
1.10.2024Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
GRAZIANO, Robert, F.Address:
Princeton, NJ, US
Name:
GUPTA, Ashok, K.Address:
Princeton, NJ, US
Name:
KIM, Su, YoungAddress:
Princeton, NJ, US
Name:
WIGGINTON, JonAddress:
Rockville, MD, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261708784 PDate:
2.10.2012Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 27.9.2017
Expires: 1.10.2018
Payer: Árnason Faktor
Number: 6
Paid: 6.9.2018
Expires: 1.10.2019
Payer: Árnason Faktor
Number: 7
Paid: 9.9.2019
Expires: 1.10.2020
Payer: Árnason Faktor
Number: 8
Paid: 9.9.2020
Expires: 1.10.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.9.2021
Expires: 1.10.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.9.2022
Expires: 1.10.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 25.9.2023
Expires: 1.10.2024
Payer: Árnason Faktor ehf.